MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy
Conclusion: miR-15b-5p represents a potentially helpful biomarker for individualized treatment decisions concerning the management of HNSCC patients.
Source: Cancer Genomics and Proteomics - Category: Cancer & Oncology Authors: AHMAD, P., SANA, J., SLAVIK, M., GURIN, D., RADOVA, L., GABLO, N. A., KAZDA, T., SMILEK, P., HORAKOVA, Z., GAL, B., HERMANOVA, M., SLAMPA, P., SLABY, O. Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Epithelial Cancer | Head and Neck Cancer | HNSCC | Squamous Cell Carcinoma | Study | Toxicology